Organisation paid for research Program year 2024 Source: CMS Open Payments

Vpcri PC

Neither a doctor nor a teaching hospital

Research payments

$553,794

69 payments

Through program year 2024, Vpcri PC is reported as receiving $553,794 in research payments, across 69 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$53,174	7
2023	Research	$117,260	19
2022	Research	$148,641	19
2021	Research	$234,649	23
2020	Research	$70	1

Breakdown

Who paid Research payments · program years 2020–2024

Pfizer Inc. $553,794 69 payments

Studies the money was for Research payments · program years 2020–2024

A Phase 3 Openlabel Multicenter Longterm Study Investigating the Safety and Efficacy of Pf06651600 in Adult and Adolescent Participants With Alopecia Areata $539,494 63 payments
A Phase 2B Randomized Double Blind Vehicle Controlled Parallelgroup Dose Ranging Study to Assess Efficacy Safety Tolerability and Pharmacokinetics of Pf06700841 Topical Cream Applied Once Or Twice Daily for 12 Weeks in Participants With Mild to Moderate Chronic Plaque Psoriasis $9,301 3 payments
A Phase 2B Randomized Doubleblind Placebocontrolled Multicenter Doseranging Study to Evaluate the Efficacy and Safety Profile of Pf06651600 With A Partially Blinded Extension Period to Evaluate the Efficacy and Safety of Pf06651600 and Pf06700841 in Subjects With Active Nonsegmental Vitiligo $4,929 2 payments
A Phase 2A Multicenter Randomized Doubleblind Placebocontrolled 16Week Study Evaluating the Safety and Efficacy of Pf06650833 Pf06700841 and Pf06826647 in Adults With Moderate to Severe Hidradenitis Suppurativa $70 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.